new glp-1 drugs project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our GLP-1 Agonists: A Comprehensive Overview

Choosing between bacteriostatic water and sterile water for injections or reconstituting peptides can affect safety and effectiveness

Conversely, to date, no cases involving children or adolescents have yet been reported (134)

In a world in which human workspans and lifespans are increasing, cognitive enhancement toolsincluding the pharmacologicalwill be increasingly useful for improved quality of life and extended work productivity, as well as to stave off normal and pathological age-related cognitive declines

Efficacy and safety of pueraria lobata extract in gray hair prevention: a randomized, double-blind, placebo-controlled study

UVA is the main waveband that demands attention in melasma treatment and post-treatment maintenance